December 15, 2008

WATSON PHARMA: To Appeal Ruling in ‘320 Patent Infringement Suit

COMPANIES: Watson Pharmaceuticals Inc
Subscribe

Watson Pharmaceuticals Inc. intends to appeal the U.S. District Court for the Southern District of Florida’s decision that the Company’s naproxen sodium product infringes Elan Corporation Plc’s patent No. 5,637,320.

On…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | United States